Dr. Ergen is from the Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee. Ms. King and Dr. Tuli are from Mid-South Dermatology and Skin Cancer Center, Bartlett, Tennessee.
The authors report no conflict of interest.
Correspondence: Elizabeth Noble Ergen, MD, Vanderbilt Division of Dermatology, 719 Thompson Ln, Ste 26300, Nashville, TN 37204 (elizabeth.n.case@vanderbilt.edu).
Cutaneous leishmaniasis should be included in the differential diagnosis for travelers returning from endemic areas who present with new skin lesions. Since no specific lesion types are pathognomonic for cutaneous leishmaniasis, tissue biopsy for histopathology and PCR are essential for diagnosis. Prevention of cutaneous leishmaniasis hinges on appropriate counseling of travelers to endemic regions.
